A national survey of physician-industry relationships.

BACKGROUND Relationships between physicians and pharmaceutical, medical device, and other medically related industries have received considerable attention in recent years. We surveyed physicians to collect information about their financial associations with industry and the factors that predict those associations. METHODS We conducted a national survey of 3167 physicians in six specialties (anesthesiology, cardiology, family practice, general surgery, internal medicine, and pediatrics) in late 2003 and early 2004. The raw response rate for this probability sample was 52%, and the weighted response rate was 58%. RESULTS Most physicians (94%) reported some type of relationship with the pharmaceutical industry, and most of these relationships involved receiving food in the workplace (83%) or receiving drug samples (78%). More than one third of the respondents (35%) received reimbursement for costs associated with professional meetings or continuing medical education, and more than one quarter (28%) received payments for consulting, giving lectures, or enrolling patients in trials. Cardiologists were more than twice as likely as family practitioners to receive payments. Family practitioners met more frequently with industry representatives than did physicians in other specialties, and physicians in solo, two-person, or group practices met more frequently with industry representatives than did physicians practicing in hospitals and clinics. CONCLUSIONS The results of this national survey indicate that relationships between physicians and industry are common and underscore the variation among such relationships according to specialty, practice type, and professional activities.

[1]  E. Campbell,et al.  Financial relationships between institutional review board members and industry. , 2006, The New England journal of medicine.

[2]  Jordan J. Cohen,et al.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. , 2006, JAMA.

[3]  D. Blumenthal Doctors and drug companies. , 2004, The New England journal of medicine.

[4]  T. Brennan,et al.  Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal Prosecution , 2004 .

[5]  V. Rolla,et al.  On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health , 2004 .

[6]  S. Hilgartner,et al.  Data withholding in academic genetics: evidence from a national survey. , 2002, JAMA.

[7]  A F Holmer,et al.  Industry strongly supports continuing medical education. , 2001, JAMA.

[8]  T. Bodenheimer,et al.  Uneasy alliance--clinical investigators and the pharmaceutical industry. , 2000, The New England journal of medicine.

[9]  D. Rothman,et al.  Medical professionalism--focusing on the real issues. , 2000, The New England journal of medicine.

[10]  A. Wazana,et al.  Physicians and the pharmaceutical industry: is a gift ever just a gift? , 2000, JAMA.

[11]  D Blumenthal,et al.  Relationships between academic institutions and industry in the life sciences--an industry survey. , 1996, The New England journal of medicine.

[12]  J. M. Thomas Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891-1900. , 2005 .

[13]  M. Angell The Truth About the Drug Companies , 2004 .

[14]  Jerry Avorn,et al.  Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs , 2004 .

[15]  C. Vries,et al.  Auditing GPs’ prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists , 1996 .